BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32328817)

  • 1. Recent and Emerging Therapies for Cutaneous Squamous Cell Carcinomas of the Head and Neck.
    Varra V; Smile TD; Geiger JL; Koyfman SA
    Curr Treat Options Oncol; 2020 Apr; 21(5):37. PubMed ID: 32328817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
    Andtbacka RH; Agarwala SS; Ollila DW; Hallmeyer S; Milhem M; Amatruda T; Nemunaitis JJ; Harrington KJ; Chen L; Shilkrut M; Ross M; Kaufman HL
    Head Neck; 2016 Dec; 38(12):1752-1758. PubMed ID: 27407058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck: A Review.
    Desai N; Divatia MK; Jadhav A; Wagh A
    Curr Oncol; 2023 Jul; 30(7):6634-6647. PubMed ID: 37504347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of High-Risk Squamous Cell Carcinoma of the Skin.
    Fu T; Aasi SZ; Hollmig ST
    Curr Treat Options Oncol; 2016 Jul; 17(7):34. PubMed ID: 27262708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement.
    Lopetegui-Lia N; Dima D; Buchberger DS; Yalamanchali A; Osantowski B; Ondeck M; Lorenz RR; Prendes B; Ku J; Lamarre E; Scharpf J; Silver NL; Schwartzman L; Geiger JL; Woody NM; Campbell SR; Koyfman SA; Yilmaz E
    Head Neck; 2023 Aug; 45(8):2149-2154. PubMed ID: 37272705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma.
    Claveau J; Archambault J; Ernst DS; Giacomantonio C; Limacher JJ; Murray C; Parent F; Zloty D
    Curr Oncol; 2020 Aug; 27(4):e399-e407. PubMed ID: 32905333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma.
    Zelin E; Zalaudek I; Agozzino M; Dianzani C; Dri A; Di Meo N; Giuffrida R; Marangi GF; Neagu N; Persichetti P; Toffoli L; Conforti C
    Curr Treat Options Oncol; 2021 Mar; 22(4):35. PubMed ID: 33725197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectables in Head and Neck Cutaneous Melanoma Treatment.
    Rumancik B; Mark L
    Otolaryngol Clin North Am; 2021 Apr; 54(2):425-438. PubMed ID: 33602521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck - a case series and review of literature.
    Olmos M; Lutz R; Büntemeyer TO; Glajzer J; Nobis CP; Ries J; Möst T; Eckstein M; Hecht M; Gostian AO; Erdmann M; Foerster Y; Kesting M; Weber M
    Front Immunol; 2022; 13():970823. PubMed ID: 36389668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
    Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E
    Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced cutaneous squamous cell carcinoma: a Mohs surgery and dermatologic oncology perspective.
    Wilmas KM; Nguyen QB; Patel J; Silapunt S; Migden MR
    Future Oncol; 2021 Dec; 17(35):4971-4982. PubMed ID: 34608809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.
    Ogata D; Tsuchida T
    Curr Treat Options Oncol; 2019 Mar; 20(4):30. PubMed ID: 30874952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
    Ashraf S; Alsharedi M
    Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Total Parotidectomy for Metastatic Cutaneous Squamous Cell Carcinoma and Malignant Melanoma.
    Thom JJ; Moore EJ; Price DL; Kasperbauer JL; Starkman SJ; Olsen KD
    JAMA Otolaryngol Head Neck Surg; 2014 Jun; 140(6):548-54. PubMed ID: 24722863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel induction therapy transoral surgery treatment paradigm with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck - Mature clinical and functional outcomes.
    Hackman TG; Patel SN; Deal AM; Neil Hayes D; Chera BS; Paul J; Knowles M; Usenko D; Grilley-Olson JE; Weissler MC; Weiss J
    Oral Oncol; 2020 Nov; 110():104957. PubMed ID: 32823258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of talimogene laherparepvec for the treatment of advanced melanoma.
    Gangi A; Zager JS
    Expert Opin Drug Saf; 2017 Feb; 16(2):265-269. PubMed ID: 27989216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.